Comparison Between Base and Cover Slide From Endoscopic Ultrasound Guided Fine Needle Aspiration for Pancreatic Cancer
NCT ID: NCT02190071
Last Updated: 2016-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
73 participants
OBSERVATIONAL
2014-06-30
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic Cancer
NCT01876069
A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS
NCT05621824
Comparison of a Novel 22-gauge Core Biopsy Needle
NCT01598194
Development of a New Immunochemistry Method Using Antibodies of Proteins Related Pancreatic Cancer
NCT04293497
A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC
NCT04794140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Pancreatic cancer is the challenging malignancy in diagnosis and treatment.
2. Recently, EUS-FNA has played a important role in diagnosing pancreatic cancer.
3. Samples from EUS-FNA are sent to following three types of preparations.
* cytologic smear (by pull apart method)
* cell block
* histologic biopsy
4. In cytologic smear method, endoscopists tend to send as many as slides, while pathologists want minimal slides if they warrant diagnostic accuracy.
5. Therefore we are going to find a point of contact between high diagnostic yield and minimal overloading of pathologist.
2. Method
1. We are going to enrolled the patients who were suspected of pancreatic cancer in previous radiologic test.
2. One identical and skilled endoscopist performs EUS-FNA with multiple punctures.
3. We get total 8 pairs of slides (= 8 covers + 8 bases).
4. All the cover slides are collected to the bottle-A, all the base slide to the bottle-B.
5. One identical and skilled pathologist inspects these slide in blind method. (She cannot show the label of bottle so that she does not know what bottle is A or B.)
6. She record the positive or negative in each bottle. (If there is only one slide is positive in malignant cell, the bottle is positive.)
7. In these manner, we collect the all subjects' cytopathologic results as a pair of outcome. All the possible combinations are following four examples:
* (cover/base) = (positive/positive) = (+/+)
* (cover/base) = (positive/negative) = (+/-)
* (cover/base) = (negative/positive) = (-/+)
* (cover/base) = (negative/negative) = (-/-)
8. Then we are going to take a two-sided non-inferiority test of proportion using McNemar's test.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* loss of slide
* patients who were diagnosed with other lesion far from pancreatic cancer in prospective confirmative tests.
* patients who refuse to participate in this study
* report of other pathologist who are not a previously-assigned pathologist
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaihwan Kim, M.D.
Role: STUDY_CHAIR
Seoul National University Bundang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNUBH-IMGPB-2014-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.